Artificial Intelligence and Machine Learning in Preeclampsia.

Area of Science:

• Reproductive medicine
• Computational biology
• Medical informatics

Background:

• Preeclampsia is a serious pregnancy complication characterized by hypertension and proteinuria after 20 weeks gestation.
• The underlying pathophysiology of preeclampsia remains incompletely understood, hindering effective prevention and treatment.
• Traditional research methods face challenges in analyzing the complex, multi-systemic nature of the disorder.

Purpose of the Study:

• To review the emerging applications of artificial intelligence (AI) and machine learning (ML) in preeclampsia research and clinical management.
• To highlight the potential of AI/ML to address current limitations in preeclampsia diagnosis, risk stratification, and treatment.
• To discuss the advancements and challenges associated with integrating AI/ML into the study of preeclampsia.

Main Methods:

• Review of recent literature on AI and ML applications in preeclampsia.
• Analysis of how data-driven approaches are being used for pattern recognition in complex biological and clinical datasets.
• Exploration of AI/ML techniques for predictive modeling, molecular discovery, and personalized medicine in preeclampsia.

Main Results:

• AI/ML demonstrate significant potential for improving early diagnosis and risk assessment of preeclampsia.
• These technologies can uncover novel insights into the molecular mechanisms and heterogeneity of preeclampsia.
• AI/ML facilitate the optimization of treatment strategies and enable advanced remote patient monitoring solutions.

Conclusions:

• Artificial intelligence and machine learning are transformative tools for advancing preeclampsia research and clinical practice.
• Successful implementation requires addressing challenges related to data quality, interpretability, and clinical validation.
• Continued development and integration of AI/ML promise to revolutionize the management of preeclampsia.